The world's largest opioid review reveals a shocking truth: your "go-to" painkillers often perform no better than a placebo for acute pain. Here is why it's time to rethink pain management.

For decades, modern medicine has operated under an unwritten rule: when pain hits hard, reach for an opioid. Whether it is the excruciating aftermath of a major surgery, the sharp agony of a fracture, or a sudden, severe medical crisis, oral opioids have long been hailed as the heavy artillery of pain management.

People have treated them as the ultimate safety net. But a groundbreaking new study has just pulled the rug out from under this deeply held belief.

In what is being recognised as the world's largest and most comprehensive review ever conducted on opioid efficacy for acute pain, researchers have dropped a medical bombshell: these powerful, highly regulated drugs often offer surprisingly little relief. In fact, for a staggering number of common conditions, they perform no better than a simple, inactive placebo.

The massive study, spearheaded by researchers at the University of Sydney and published in a leading medical journal, didn't just look at an isolated trial. It systematically brought together evidence from 59 systematic reviews, analysing data spanning more than 50 different acute pain conditions across both children and adults.

According to the study's lead authors, oral opioids were found to be only marginally better than a placebo for acute musculoskeletal pain, the exact type of back, muscle, or joint injury for which they are routinely prescribed.

Even when they did manage to blunt the sharp edges of pain, the relief was remarkably short-lived, typically wearing off within a mere six to 48 hours after starting the treatment.

Source:Ndtv